Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
1999-04-07
2001-03-06
Weddington, Kevin E. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S724000, C424S602000, C424S646000, C424S682000
Reexamination Certificate
active
06197758
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of Invention
The present invention relates to postgastrectomic mineral supplements and, more specifically, to therapeutic agents for postgastrectomic syndrome. The present invention also relates to methods for supplying Postgastrectomic mineral and methods for treating Postgastrectomic Syndrome.
2. Description of the Related Art
Gastric ulcers and stomach cancers that are caused by such factors as stresses arising from a complex modern society are typical adult diseases. Gastrectomy is performed for treating a variety of gastric diseases, most frequently, for treating stomach cancers and gastric ulcers.
Various mechanical or metabolic disorders occur after gastrectomy. For example, disorders such as postoperative hemorrhage, satural failure, and postoperative pancreatitis occur immediately or in the early stage after gastrectomy, while dumping syndrome, diarrhea, bone metabolism disorders and anemia are major disorders which occur after a certain period of time.
Bone metabolic disorders are mainly caused by malabsorption of calcium or vitamin D. Specifically, it is thought that bone metabolic disorders are caused by an insufficient uptake of calcium due to a reduction in the amount of diets and reduced solubility of calcium as a result of the reduced secretion of gastric acid due to the gastrectomy as well as a decrease thereby in calcium absorption. Moreover, diarrhea, dumping syndrome and the like are thought to interfere with the absorption of vitamin D that is essential for calcium absorption from the intestinal tract, triggering the resorption of calcium from the bones to the blood and the gradual development of bone lesions.
The reduced secretion of gastric hydrochloric acid as a result of gastrectomy also interferes with the absorption of iron which triggers a depletion of iron stored in the body to conceivably cause a form of anemia known as iron deficiency anemia. Further, after total gastrectomy, the lack of secretion of intrinsic factors such as transcobalamin from the gastric membrane will interfere with the absorption of vitamin B12, even if vitamin B12 is contained in sufficient quantities in ingested foods. This decreases stores of vitamin B12 in the liver to cause agastric pernicious anemia.
Thus, it was known that it is necessary to conduct adequate therapeutic management and alimentary therapy for a certain period after gastrectomy. For example, patients with bone metabolic disorders are fed diets rich in calcium, optionally, vitamin D or calcitonin formulations in combination. Anemia patients are fed diets rich in iron, optionally, iron formulations or vitamin B12. However, no effective postgastrectomic mineral supply has been reported and the management of postgastrectomic care may would be improved.
Meanwhile, indigestible oligosaccharides (particularly fructo-oligosaccharides) were reported to promote mineral absorption in healthy humans (Japanese Patent Laid-open No. 145064/1995 and Japanese Patent Laid-open No. 252156/1995).
SUMMARY OF THE INVENTION
The present inventors have now found that indigestible oligosaccharides and indigestible sugar alcohols extremely promote absorption of minerals (particularly, calcium and iron) in patients who underwent gastrectomy. Compared with healthy humans, patients who underwent gastrectomy have absorption disorders or are apt to have absorption disorders in the gastrointestinal tract. It was surprising to the inventors that indigestible oligosaccharides and indigestible sugar alcohols promote mineral absorption in patients who underwent gastrectomy.
Thus, the objective of the present invention is to provide a composition and method which effectively supplies minerals such as calcium and iron to patients who underwent gastrectomy.
Another objective of the present invention is to provide a composition and method for the treatment of postgastrectomic syndrome.
The composition for postgastrectomic mineral supply and the composition for the treatment of postgastrectomic syndrome according to the present invention comprise an indigestible oligosaccharide and/or an indigestible sugar alcohol and a mineral.
REFERENCES:
patent: 3794722 (1974-02-01), Taya
patent: 5434061 (1995-07-01), Ishiguro et al.
patent: 5439882 (1995-08-01), Feola et al.
patent: 5900255 (1999-05-01), Ohta et al.
patent: 57-156419 (1982-09-01), None
patent: 59-199626 (1984-11-01), None
patent: 5-000067 (1993-01-01), None
patent: 6-116154 (1994-04-01), None
patent: 7-069902 (1995-03-01), None
patent: 7-145064 (1995-06-01), None
patent: 7-252156 (1995-10-01), None
patent: 8-157379 (1996-06-01), None
T. Ebata et al., “Nutritional Control Before and After Gastric Cancer Operation”, (in Japanese), Cancer & Chemotherapy, 15, (1988), pp. 820-826.
Adachi Takashi
Ohta Atsutane
Ohtsuki Masako
Takizawa Toshio
Meiji Seika Kaisha Ltd.
Weddington Kevin E.
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Methods for supplying postgastrectomic mineral and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for supplying postgastrectomic mineral and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for supplying postgastrectomic mineral and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2460147